13^th International Conference on Pharmacoepidemiology and Clinical Research December 05-06, 2022 Toronto, Canada

Conference Series Ltd is delighted to extend our warm welcome to you all to participate in the 13th International Conference on Pharmacoepidemiology and Clinical research,, scheduled  during December 22-23,2022. at Toronto, Canada. , with the theme "Focused on all research activities for optimal use and safety of medication”.

Experts Meeting to join the Global scientific influencers from  Asia, Middleeast, Europe, USA(America) and Africa at Pharmacoepidemiology and Clinical research Congress, organised at Toronto,Canada December 22-23,2022. with a main theme “Focused on all research activities for optimal use and safety of medication”.

Pharmacoepidemiology Congress includes a wide range of Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions and extensive networking and B2B interactions.

 Track 1: Pharmacoepidemiology and Clinical Research:

Pharmacoepidemiology is an extensive area of science which involves uses and effects of drugs in larger arena of population. Pharmacoepidemiology is a bridge of science which connects both pharmacology and epidemiology enhancing the informative study on topics apparently related to Pharmacoepidemiology, Pharmacokinetics, Adverse drug reactions, Public health, Epidemiologic methods, Medication adherence and Drug safety, Pharmacovigilance, effects of genetic variation on drug effect, duration-response relationships, clinical effects of drug-drug interactions. This topic serves as a best way for Researchers to express their findings as research presentations on an array of Pharmacoepidemiology and Drug Safety. The main aim of Pharmacoepidemiology within the industry is to protect patients from unnecessary medication hazards by identifying the adverse effects, elucidating pre-disposing factors, refuting false safety signals and quantifying risk in relation to benefit. Clinical research  is the branch of science that involves the use of various medications, clinical therapeutics, medical and clinical devices, equipment and medical products for diagnosis and treatment of human disorders, diseases and patient safety.

Related Associations or Societies:

International Society for Pharmacoepidemiology, Center for Drug Safety and Effectiveness,  Center for Public Health and Human Rights, Center  for Health Services  and Outcomes Research, International Pharmaceutical Federation, International Society of Pharmacovigilance .

Track 2: Pharmacotherapy and Drug Safety:

Pharmacotherapy also known as drug therapy is the use of a medical therapies (Surgical, Chemotherapy, Physical therapy, Radiation therapy) to treat disease. Drugs interact with receptors or enzymes present in cells, which promote healthy functioning and shave or cure illness. Drug Safety refers to the pharmacological science that ensures safety and is related to the collection, detection, assessment, monitoring, and prevention of adverse drug effects with pharmaceutical products. Safety monitoring in clinical trials involves the collection of adverse events, laboratory investigations including the planning, execution, data analysis and reporting of the safety information and details of the clinical examination of patients.

Related Associations or Societies:

International Society for Pharmacoepidemiology, Center for Drug Safety and Effectiveness,  Center for Public Health and Human Rights, Center  for Health Services  and Outcomes Research, International Pharmaceutical Federation, International Society of Pharmacovigilance .

Track 3: Action of Drugs :

Action of Drugs also known Pharmacodynamics. It refers to the study of Drugs, its biochemical, physiologic effects, the mechanisms and its action on the body or on microorganisms and other parasites within or on the body. It deals with drug action, which is the initial consequence of a drug-receptor interaction, and drug effect, which refers to the subsequent effects. The drug action of digoxin, for example: The inhibition of membrane Na+/K+-ATPase; the drug effect is augmentation of cardiac contractility. In this example, the clinical response may comprise of improved exercise tolerance.

Related Associations or Societies:

International Society for Pharmacoepidemiology, Center for Drug Safety and Effectiveness,  Center for Public Health and Human Rights, Center  for Health Services  and Outcomes Research, International Pharmaceutical Federation, International Society of Pharmacovigilance .

Track 4: Clinical Research:

Clinical research  is the branch of science that involves the use of various medications, clinical therapeutics, medical and clinical devices, equipment and medical products for diagnosis and treatment of human disorders, diseases and patient safety.

Related Associations or Societies:

International Society for Pharmacoepidemiology, Center for Drug Safety and Effectiveness,  Center for Public Health and Human Rights, Center  for Health Services  and Outcomes Research, International Pharmaceutical Federation, International Society of Pharmacovigilance .

Track 5:Clinical Trials:

Clinical trials describe the distinct procedures followed in development of new drugs. These are the characteristic studies intended for the treatment of behavioural symptoms among the medical intervention and a health outcome. Clinical trials comprise patient data, disease mechanisms, therapeutic interventions, epidemiology, clinical medicine, preclinical and clinical pharmacology, immunology, toxicological studies. Clinical trials consist of experimental clinical trials scrutinizes the new treatment replacing the placebo or existing alternative treatments and  safety methodology using data from observation of patients treated in clinical. Clinical data is the key feature translating basic research into medical care. The perfect conclusion of clinical trials is minimize risks, extend benefits and optimal use of an intervention of therapeutic drugs .

Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry .

Track 6: Pharmacology:

Pharmacology  is the study of interaction between substances with living organisms to produce a change in function. It deals with the research, discovery, and characterization of chemicals that show biological effects and the illumination of cellular and organism function in relation to these chemicals. If substances have medicinal properties, they are defined as pharmaceuticals. The Pharmacology encompasses mechanisms of drug action, drug composition and properties, interactions, toxicology, therapies, medical applications, and anti pathogenic capabilities.

Related Associations or Societies:

International Society for Pharmacoepidemiology, Center for Drug Safety and Effectiveness,  Center for Public Health and Human Rights, Center  for Health Services  and Outcomes Research, International Pharmaceutical Federation, International Society of Pharmacovigilance .

Track 7: Pharmacoepidemiology and Public Health:

Pharmacoepidemiology is an extensive area of science which involves uses and effects of drugs in larger arena of population. Pharmacoepidemiology is a bridge of science which connects both pharmacology and epidemiology enhancing the informative study on topics apparently related to Pharmacoepidemiology, Pharmacokinetics, Adverse drug reactions, Public health, Epidemiologic methods, Medication adherence and Drug safety, Pharmacovigilance, effects of genetic variation on drug effect, duration-response relationships, clinical effects of drug-drug interactions. This topic serves as a best way for Researchers to express their findings as research presentations on an array of Pharmacoepidemiology and Drug Safety. Public health describes “the science and art of preventing disease, lengthening life and further human health through methodized efforts and informed choices of society, organizations, public and private, communities and individuals." It is concerned with threats to health based on population health analysis .The focus of public health intercession is to promote health and quality of life through obstruction and treatment of disease and other physical and mental health conditions. This is done through supervision of cases and health indicators, and through advancement of healthy behaviours

Related Associations or Societies:

Society for Clinical Trials  Association of Clinical Research  The Society of Clinical Research Associates  Clinical Research Society  American Association of Pharmaceutical Scientists Association of British Pharmaceutical Industry  International Society for Pharmacoepidemiology

Track 8: Genetic Epidemiology:

Genetic epidemiology refers to “the role of genetic factors and genetic variations for determining health, disease in families and in populations and the interplay of such genetic factors with environmental factors. Genetic epidemiology seeks to derive a statistical and quantitative analysis of how genetics work in huge groups.

Related Associations or Societies:

International Society for Pharmacoepidemiology Center for Drug Safety and Effectiveness Center for Public Health and Human Rights Center  for Health Services  and Outcomes Research  International Pharmaceutical Federation   International Society of Pharmacovigilance

Track 9:Drug Discovery and Drug Development:

Pharma compounds which were developed in the olden days were discovered and developed either by identifying the active ingredient from traditional remedies or by serendipitous discovery. But the advancements in the science and technology has made the job easier by controlling them at molecular and physiological level. During the phase of drug discovery main reason for the disease is identified and the possible pharmacological molecules are discovered. Later effect of that molecule on animals, humans is tested and if further improvements to be made, are performed. This involves many steps like identifying the reason for disease, lead identification, lead development, lead optimization, testing, and marketing.

Related Associations or Societies:

Society for Clinical Trials  Association of Clinical Research  The Society of Clinical Research Associates  Clinical Research Society  American Association of Pharmaceutical Scientists Association of British Pharmaceutical Industry  International Society for Pharmacoepidemiology

Track 10: Clinical Data Management:

Databases contain professional assessment of the potential of drugs and permit the risk- profit analysis of medicinal products taking under consideration new and emerging information, within the context of additive data. These databases offer programming of alerts for fast cases, follow-up cases and reports submission to fulfil regulative timeline compliance. Data sources of pharmacoepidemiological databases are CPRD (Clinical Practice Research Data link), IMS Health Disease Analyser databases, PHARMO, Vigibase and Eudravigilance. Pharmacoepidemiology research studies may involve either data collected prospectively for the purpose of the particular study i.e. primary data, or data that were already collected for another purpose – as part of administrative records or patient health care , which is called secondary data.

Related Associations or Societies:

International Society for Pharmacoepidemiology Center for Drug Safety and Effectiveness Center for Public Health and Human Rights Center  for Health Services  and Outcomes Research  International Pharmaceutical Federation   International Society of Pharmacovigilance

Track 11:Clinical Pharmacy:

Clinical Pharmacy and Pharmacy Practice involves developing the professional roles of pharmacists and is the order of drug store which includes adding to the expert parts of drug specialists. It includes Disease-state management, Clinical drug interventions, Pharmacy professional development and pharmaceutical care, pharmaceutical compounding and health psychology, patient care, drug abuse prevention, prevention of drug interactions or minimisation of adverse events and drug incompatibility and community pharmacy.

Related Associations or Societies:

Society for Clinical Trials  Association of Clinical Research  The Society of Clinical Research Associates  Clinical Research Society  American Association of Pharmaceutical Scientists Association of British Pharmaceutical Industry  International Society for Pharmacoepidemiology

Track 12:Pharmacovigilance and its Significance:

Pharmacovigilance plays a key role in all phases of clinical trials, including the planning, execution, data analysis and reporting of safety information and also bears an important responsibility for the expedited reporting of individual cases and safety updates required for regulatory authorities. The concept of Pharmacovigilance and its Significance enhances the impact of healthcare management on patient welfare and public health. Pharmacovigilance legislation gives an outlook on the rules and regulations to follow in Pharmacovigilance practice. The Role of Pharma industries in the improvement of Pharmacovigilance system is very crucial to maintain the safety data, detection and evaluation of drug safety signals through manual and medical devices reporting. Pharmacovigilance scope also deals as Eco Pharmacovigilance (EPV), Pharmacoenvironmentology and Pharmacovigilance in herbal medicines. In addition, data from observational epidemiological studies are playing an increasingly important role.

Related Associations or Societies:

International Society for Pharmacoepidemiology Center for Drug Safety and Effectiveness Center for Public Health and Human Rights Center  for Health Services  and Outcomes Research  International Pharmaceutical Federation   International Society of Pharmacovigilance .

Track 13: Risk Management:

Pharma Risk Management was designed as a set of Pharmacovigilance activities and interventions designed to identify, characterise, prevent or minimise risks of medicinal and therapeutic products including the assessment of the effectiveness of their clinical reactions, interventions and combination therapies. Drug industry need to promote companies in Pharmacovigilance practice to use information technology and provide efficient software to implement the risk minimisation plans in drug development and manufacture. Pharmaceutical risk management monitors unlicensed, off labels and orphan drugs ,risk management labelling, regulatory decisions, legal protection, intellectual property, enforcement, marketing, and company reputation.

Related Associations or Societies:

International Society for Pharmacoepidemiology Center for Drug Safety and Effectiveness Center for Public Health and Human Rights Center  for Health Services  and Outcomes Research  International Pharmaceutical Federation   International Society of Pharmacovigilance

Track 14: Regulatory Affairs:

Regulatory affairs is developed to protect public health by controlling the safety and efficacy of medical devices and pharmaceutical drug products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics and complementary medicines. Regulatory affairs (RA), also called government affairs, are a profession within regulated industries, such as pharmaceuticals, medical devices, energy, banking, telecom etc.

Related Associations or Societies:

Society for Clinical Trials  Association of Clinical Research  The Society of Clinical Research Associates  Clinical Research Society  American Association of Pharmaceutical Scientists Association of British Pharmaceutical Industry  International Society for Pharmacoepidemiology

Market analysis

The global Pharmacoepidemiology and clinical research market has been thought to purview USD 14.2 billion in 2016-2017 and is calculated to reach around USD 22 billion by the year 2021, growing at a CAGR (compounded annual growth rate) of 7.5%, during the forecast period 2016 to 2021. Clinical research denotes Clinical trial as a branch of clinical research that follows a standardized protocol. Clinical research is especially performed to estimate safety and efficacy of the advanced drug. Clinical trial data is indispensable for further approval of the drug and to import it into the market.

Clinical research is one of the basic technologies to precipitate the revolution of the entire country-Malaysia into a knowledge based economy and an industrialized nation by year 2020.

This sector is predicted to be upto worth US $1.37 million, and is expected to rise at a CAGR of 10.5%.

The United States and Canada have the apical market share in the Clinical research and clinical trials market, followed by Europe where Germany leads the market pursued by Poland and Western Europe. Asia is one of the quickest growing markets. India, China, Singapore and South Korea are the extensive players involved in this market. The Asia-Pacific region has turn into a beautiful destination for companies contributing CTMS software. The rise in this regional segment can be connected to a number of factors, such as rising number of clinical trials, existence of a broad number of CROs, government initiatives, boost in outsourcing of clinical trials, availability of large and diverse patient population, presence of less stringent regulatory guidelines as correlated to developed nations, and cost advantages offered by various countries.

Leading companies are outsourcing their clinical trials to the APAC region due the lower cost of the clinical trials in the region as compared to the developed regions (Europe and North America).This high growth is attributed to the fact that the cost involved in performing a trial is less and the huge domain it provides in the aspect of diseases and patients.

The increasing disease burden is propelling the pharmaceutical and biotechnology industry to bring up new chemical entities into the market at a higher rate. Most companies are outsourcing the clinical trials of their newly developed drugs to various contract research organizations as this could save them the hassles of regulatory issues and patient recruitment burden from the research and development phase. Pharmacoepidemiology and Clinical research the drug to be tested for safety by different ethnic population. Due to the higher medical needs and increasing disease prevalence, developing countries are becoming a hub for clinical trial execution. Since 2006, there has been an increased number of trials registered worldwide and it is estimated to increase further in the coming years, which would contribute to the market growth.

The report analyzes the various trends and key opportunities in clinical trials market, and provides the market share of leading segments and geographical parts. This report contributes strategic insights on industry competition, and disguise key facts, business overview, service portfolio, SWOT scrutiny and financial analysis of leading players in the market. The primary segments subsidizing the growth strategies in global market of Clinical research are:    

· Clinical solution vendors
· Clinical research organizations
·Pharmaceutical/biopharmaceutical companies
·Research and development (R&D) companies
· Business research and consulting service providers
·Medical research laboratories
· Healthcare IT service providers

Pharmaceutical Societies and Associations across the world: 

Center for Drug Safety and Effectiveness
Center for Public Health and Human Rights
Center for Health Services and Outcomes Research
European federation on Pharmaceutical sciences
Pharmaceutical Research and Manufacturers of America
National Pharmaceutical Association
Association of Pharmacy Professionals
Pharmaceutical Society of Ireland
The Pharmaceutical Association of Israel
Kuwait Pharmaceutical Association
Pharmaceutical Society Of New Zealand
Pharmaceutical Association of Mauritius
International Pharmaceutical Federation (FIP)
European Pharmaceutical Union (EPU)
Pharmaceutical Group of the European Union (PGEU)
European Association of Employed Community Pharmacists in Europe (EPhEU)
Australian College of Pharmacy
Pharmaceutical Society of Australia
The Pharmacy Guild of Australia
Canadian Pharmacists Association

Visa Application Documents You should only apply for business visas to attend and attend conferences. Contact your nearest Toronto, Canada Travel Agency/Visa Information Center/Embassy for the correct application form.

All visas for the visit to Vancouver, Canada are processed by the respective embassy authorities in the correct way only after the presentation of the corresponding documents.

If no documents are provided or if the guidelines are not followed, the competent authorities hold the right to reject/cancel the visas.

The minimum documents that may be required when applying for the visa from / Toronto, Canada  include:

• Official Letter of Invitation
• Letter of Acceptance/Approval for abstracts (if you are a speaker)
• Proof of payment receipt for registration
• Hotel Booking Confirmation Letter for accommodation issued on conference letterhead

Note: For the Letter of Invitation and Accommodation Confirmation, payment of registration and accommodation fees is a prerequisite. Please contact us for more information